Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015
Standard
Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015. / Jablonka, Alexandra; Solbach, Philipp; Wöbse, Michael; Manns, Michael P; Schmidt, Reinhold E; Wedemeyer, Heiner; Cornberg, Markus; Behrens, Georg M N; Hardtke, Svenja.
In: EUR J GASTROEN HEPAT, Vol. 29, No. 8, 08.2017, p. 939-945.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015
AU - Jablonka, Alexandra
AU - Solbach, Philipp
AU - Wöbse, Michael
AU - Manns, Michael P
AU - Schmidt, Reinhold E
AU - Wedemeyer, Heiner
AU - Cornberg, Markus
AU - Behrens, Georg M N
AU - Hardtke, Svenja
PY - 2017/8
Y1 - 2017/8
N2 - BACKGROUND: Migration because of miscellaneous political crises in countries in the Middle East and Africa is a global challenge for whole Europe from an economic, social, and public health view. There is an urgent need to generate comprehensive, evidence-based data to expedite further screening and vaccination strategies.METHODS: A total of 604 individuals ranging in age from 2 to 68 years who enrolled at a single reception center were tested for the prevalence of serologic markers for hepatitis virus types A, B, C, D, and E (HAV, HBV, HCV, HDV, HEV), respectively.RESULTS: Anti-HAV antibody prevalence was 91.2 and 70.3% in children younger than 18 years of age. The prevalence of anti-HEV antibodies was 20.1% among the individuals. 3.0% were positive for hepatitis B surface antigen, whereas 15.2% tested positive for anti-hepatitis B core antigen. None of the refugees tested positive for anti-HDV. 14.1% of refugees were vaccinated against hepatitis B and had a protective anti-hepatitis B surface level of at least 10 mIU/ml. Significant differences in vaccination status were found between the regions (Eastern Mediterranean Region with 77/482 (16.0%; 95% confidence interval=12.7-19.3%) versus African Region with 1/55 (1.8%; 95% confidence interval=0-5.0%). The prevalence of anti-HCV antibodies was 1.2% (n=7), with 0.7% HCV RNA positivity; 16.7% of hepatitis B surface antigen-positive individuals were HCV coinfected (n=3).CONCLUSION: The prevalence of refugees with previous exposure to hepatitis viruses was higher than that in the general German population, but lower than in other migrant populations in Germany. The vaccination status against hepatitis B was poor.
AB - BACKGROUND: Migration because of miscellaneous political crises in countries in the Middle East and Africa is a global challenge for whole Europe from an economic, social, and public health view. There is an urgent need to generate comprehensive, evidence-based data to expedite further screening and vaccination strategies.METHODS: A total of 604 individuals ranging in age from 2 to 68 years who enrolled at a single reception center were tested for the prevalence of serologic markers for hepatitis virus types A, B, C, D, and E (HAV, HBV, HCV, HDV, HEV), respectively.RESULTS: Anti-HAV antibody prevalence was 91.2 and 70.3% in children younger than 18 years of age. The prevalence of anti-HEV antibodies was 20.1% among the individuals. 3.0% were positive for hepatitis B surface antigen, whereas 15.2% tested positive for anti-hepatitis B core antigen. None of the refugees tested positive for anti-HDV. 14.1% of refugees were vaccinated against hepatitis B and had a protective anti-hepatitis B surface level of at least 10 mIU/ml. Significant differences in vaccination status were found between the regions (Eastern Mediterranean Region with 77/482 (16.0%; 95% confidence interval=12.7-19.3%) versus African Region with 1/55 (1.8%; 95% confidence interval=0-5.0%). The prevalence of anti-HCV antibodies was 1.2% (n=7), with 0.7% HCV RNA positivity; 16.7% of hepatitis B surface antigen-positive individuals were HCV coinfected (n=3).CONCLUSION: The prevalence of refugees with previous exposure to hepatitis viruses was higher than that in the general German population, but lower than in other migrant populations in Germany. The vaccination status against hepatitis B was poor.
KW - Adolescent
KW - Adult
KW - Aged
KW - Biomarkers/blood
KW - Child
KW - Child, Preschool
KW - Emigrants and Immigrants
KW - Emigration and Immigration
KW - Female
KW - Germany/epidemiology
KW - Hepatitis Antibodies/blood
KW - Hepatitis B Surface Antigens/blood
KW - Hepatitis Viruses/genetics
KW - Hepatitis, Viral, Human/blood
KW - Humans
KW - Infant
KW - Male
KW - Middle Aged
KW - RNA, Viral/genetics
KW - Refugees
KW - Seroepidemiologic Studies
KW - Vaccination
KW - Viral Hepatitis Vaccines/administration & dosage
KW - Viral Load
KW - Young Adult
U2 - 10.1097/MEG.0000000000000889
DO - 10.1097/MEG.0000000000000889
M3 - SCORING: Journal article
C2 - 28492419
VL - 29
SP - 939
EP - 945
JO - EUR J GASTROEN HEPAT
JF - EUR J GASTROEN HEPAT
SN - 0954-691X
IS - 8
ER -
